| Balance Sheets | 2025-10-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 2,714,012 | |||
| Short-term investments | 7,461,960 | |||
| Amounts receivable and prepaid expenses | 1,172,435 | |||
| Total current assets | 11,348,407 | |||
| Equity investment in bc therapeutics | 554,448 | |||
| Intangible assets, net | 180,707 | |||
| Property and equipment, net | 273,980 | |||
| Long term prepaid expenses | 717,508 | |||
| Total non-current assets | 1,726,643 | |||
| Total assets | 13,075,050 | |||
| Trade payables | 2,128,915 | |||
| Accrued expenses and other payables | 1,188,858 | |||
| Total current liabilities | 3,317,773 | |||
| Warrant liability | 406,873 | |||
| Total non-current liabilities | 406,873 | |||
| Share capital of no par value authorized unlimited at october 31, 2025 and july 31, 2025 issued and outstanding 1,883,906 shares at october 31, 2025 and july 31, 2025, respectively | 101,739,923 | |||
| Share-based payment reserved | 10,610,826 | |||
| Warrant reserve | 17,719,026 | |||
| Accumulated other comprehensive loss | -138,684 | |||
| Non-controlling interest | -627,558 | |||
| Accumulated deficit | -119,953,129 | |||
| Total shareholders equity | 9,350,404 | |||
| Total liabilities and shareholders equity | 13,075,050 | |||
BriaCell Therapeutics Corp. (BCTXW)
BriaCell Therapeutics Corp. (BCTXW)